ARDIZZONI, ANDREA
ARDIZZONI, ANDREA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04-2016
2025 Gelsomino, Francesco; Boni, Luca; Tiseo, Marcello; Ricciardi, Serena; Rocco, Danilo; Cortinovis, Diego L; Proietto, Manuela; Cogoni, Alessio; Pasello, Giulia; Camerini, Andrea; Sperandi, Francesca; Colantonio, Ida; Metro, Giulio; Mazzoni, Francesca; Baldini, Editta; Veccia, Antonello; Bennicelli, Elisa; Cecilia Bettini, Anna; Tognetto, Michele; Ardizzoni, Andrea
Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma
2025 Francia, A.; Girone, C.; Filippini, D. M.; Querzoli, G.; Fermi, M.; Miroglio, C.; Montacci, E.; Ardizzoni, A.; Lauriola, M.; Romaniello, D.
Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening
2025 Francia, A.; Girone, C.; Filippini, D. M.; Querzoli, G.; Fermi, M.; Venturoli, S.; Degiovanni, A.; Castellano-Sanz, E.; Miroglio, C.; Montacci, E.; Ardizzoni, A.; Lauriola, M.; Romaniello, D.
Diagnostic Accuracy of Procalcitonin in the Diagnosis of Sepsis in Cancer Patients Hospitalized for Infection
2025 Salvatore, V.; Viola, A.; Spezzano, A.; Aquilino, A.; Barili, L.; Caprino, M.; Floresta, M.; Momoli, G.; Romiti, A.; Scurria, G.; Sirna, M.; Paccapelo, A.; Nannini, M.; Ardizzoni, A.; Giostra, F.
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
2025 Di Federico, A.; Wang, K.; Chen, M. F.; Barsouk, A. A.; Pagliaro, A.; Chen, L. N.; Ogliari, F. R.; Stockhammer, P.; Thawani, R.; Raslan, S.; Gariazzo, E.; Fusco, F.; Hambelton, G. M.; Citarella, F.; Meyer, D.; Aldea, M.; De Giglio, A.; Alessi, J. V.; Pecci, F.; Gelsomino, F.; Corassa, M.; Vokes, N. I.; Wang, X.; De Biase, D.; Abu Rous, F.; Areesawangkit, P.; Elghawy, O.; Cortellini, A.; Metro, G.; Ferrara, R.; Awad, M. M.; Pabani, A.; Murray, J. C.; Cappuzzo, F.; Garassino, M. C.; Dagogo-Jack, I.; Riely, G.; Grant, M.; Herzberg, B. O.; Ardizzoni, A.; Planchard, D.; Johnson, B. E.; Langer, C. J.; Offin, M.; Negrao, M. V.; Ricciuti, B.
First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC
2025 Pecci, F.; Li, H.; Di Federico, A.; Wu, J.; Chen, H.; Gariazzo, E.; Mantuano, F.; Garbo, E.; Aldea, M.; Santo, V.; Gibbons, D.; Tran, H.; Paoloni, F.; De Almeida, G. R.; Metro, G.; De Giglio, A.; Gelsomino, F.; Wang, X.; Tiseo, M.; Rotow, J.; Ardizzoni, A.; Lee, J. J.; Awad, M. M.; Addeo, A.; Hong, L.; Negrao, M. V.; Janne, P. A.; Heymach, J. V.; Zhang, J.; Ricciuti, B.; Le, X.
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%
2025 De Giglio, A.; Zullo, L.; Di Federico, A.; Cani, M.; Aldea, M.; Soldato, D.; Dall'Olio, F. G.; Mantuano, F.; Sperandi, F.; Favorito, V.; Sadowska, A.; Hendriks, L. E. L.; Gorria, T.; Mezquita, L.; Tabbo, F.; Novello, S.; Gelsomino, F.; Besse, B.; Ardizzoni, A.
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
2025 Di Federico, A.; Stumpo, S.; Mantuano, F.; De Giglio, A.; Lo Bianco, F.; Pecci, F.; Alessi, J. V.; Wang, X.; Sperandi, F.; Melotti, B.; Gelsomino, F.; Skoulidis, F.; Garassino, M. C.; Peters, S.; Awad, M. M.; Ardizzoni, A.; Ricciuti, B.
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
2025 Di Federico, A; Hong, L; Elkrief, A; Thummalapalli, R; Cooper, A J; Ricciuti, B; Digumarthy, S; Alessi, J V; Gogia, P; Pecci, F; Makarem, M; Gandhi, M M; Garbo, E; Saini, A; De Giglio, A; Favorito, V; Scalera, S; Cipriani, L; Marinelli, D; Haradon, D; Nguyen, T; Haradon, J; Voligny, E; Vaz, V; Gelsomino, F; Sperandi, F; Melotti, B; Ladanyi, M; Zhang, J; Gibbons, D L; Heymach, J V; Nishino, M; Lindsay, J; Rodig, S J; Pfaff, K; Sholl, L M; Wang, X; Johnson, B E; Jänne, P A; Rekhtman, N; Maugeri-Saccà, M; Heist, R S; Ardizzoni, A; Awad, M M; Arbour, K C; Schoenfeld, A J; Vokes, N I; Luo, J
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates
2025 Dall'Olio, Filippo G; Zrafi, Wael; Roelants, Veronique; Ambrosini, Valentina; Fourquet, Aloyse; Mitea, Cristina; Passiglia, Francesco; Bauckneht, Matteo; Bonardel, Gerald; Conci, Nicole; Benitez, Jose Carlos; Arena, Vincenzo; Namour, Céline; Naigeon, Marie; Monnet, Isabelle; Beshiri, Kristi; Hoton, Delphine; Dursun, Safiye; Danlos, François Xavier; Argalia, Giulia; Aldea, Mihaela; Rovera, Guido; Derosa, Lisa; Iebba, Valerio; Gietema, Hester A; Gounant, Valerie; Lacroix, Valérie; Remon, Jordi; Gautheret, Daniel; Chaput, Nathalie; Job, Bastien; Kannouche, Patricia L; Velasco-Nuño, Monica; Zitvogel, Laurence; Cella, Eugenia; Chícharo De Freitas, José Reinaldo; Vasseur, Damien; Bettaieb, Mohamed Aymen; Tagliamento, Marco; Hendriks, Lizza; Italiano, Antoine; Planchard, David; Marabelle, Aurelien; Barlesi, Fabrice; Novello, Silvia; De Andreis, Desiree; Aboubakar Nana, Frank; Ardizzoni, Andrea; Zalcman, Gerard; Garcia, Camilo; Besse, Benjamin
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
2025 Angelicola, Stefania; Giunchi, Francesca; Ruzzi, Francesca; Frascino, Mariateresa; Pitzalis, Mary; Scalambra, Laura; Semprini, Maria Sofia; Pittino, Olga Maria; Cappello, Chiara; Siracusa, Irene; Chillico, Ilaria Candida; Di Noia, Martina; Turato, Cristian; De Siervi, Silvia; Lescai, Francesco; Ciavattini, Teresa; Lopatriello, Giulia; Bertoli, Luca; De Jonge, Hugo; Iamele, Luisa; Altimari, Annalisa; Gruppioni, Elisa; Ardizzoni, Andrea; Rossato, Marzia; Gelsomino, Francesco; Lollini, Pier-Luigi; Palladini, Arianna
Pembrolizumab-Induced Erosive Lichenoid Reaction in a Patient With Metastatic Lung Adenocarcinoma: A Case Report
2025 Venturi, F.; Melotti, B.; Lambertini, M.; Alessandrini, A.; Ardizzoni, A.; Dika, E.
Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting
2025 de Marinis, Filippo; Ardizzoni, Andrea; Attili, Ilaria; Bonanno, Laura; Bria, Emilio; Cortinovis, Diego Luigi; Margaritora, Stefano; Mazzoni, Francesca; Mercadante, Edoardo; Morabito, Alessandro; Petrella, Francesco; Rea, Federico; Salvi, Rosario; Solli, Piergiorgio; Spaggiari, Lorenzo; Voltolini, Luca; Gridelli, Cesare
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status
2025 De Giglio, Andrea; De Biase, Dario; Favorito, Valentina; Maloberti, Thais; Di Federico, Alessandro; Zacchini, Federico; Venturi, Giulia; Parisi, Claudia; Gustavo Dall'Olio, Filippo; Ricciotti, Ilaria; Gagliano, Ambrogio; Melotti, Barbara; Sperandi, Francesca; Altimari, Annalisa; Gruppioni, Elisa; Tallini, Giovanni; Gelsomino, Francesco; Montanaro, Lorenzo; Ardizzoni, Andrea
Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer
2024 Girone, Cinzia; Mazzeschi, Martina; Sgarzi, Michela; Pagano, Federica; Romaniello, Donatella; Morselli, Alessandra; Montacci, Elisa; Borrelli, Francesco; Miroglio, Chiara; Francia, Anna; Timmermans, Jasmine; Ambrosi, Francesca; Fiorentino, Michelangelo; Sargenti, Azzurra; Rihawi, Karim; Ardizzoni, Andrea; Lauriola, Mattia
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)
2024 Pizzutilo, E G; Agostara, A G; Oresti, S; Signorelli, D; Stabile, S; Lauricella, C; Motta, V; Amatu, A; Ruggieri, L; Brambilla, M; Occhipinti, M; Proto, C; Giusti, R; Filetti, M; Genova, C; Barletta, G; Gelsomino, F; Bennati, C; Siringo, M; Di Fazio, G R; Russano, M; Montrone, M; Gariazzo, E; Roca, E; Bordi, P; Delmonte, A; Scimone, A; Belluomini, L; Mazzoni, F; Carta, A; Pelizzari, G; Viscardi, G; Morgillo, F; Gelibter, A; Gori, S; Berardi, R; Cortinovis, D; Ardizzoni, A; Veronese, S M; Sartore-Bianchi, A; Giannetta, L G; Cerea, G; Siena, S
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience
2024 Parisi, Claudia; Benitez, José Carlos; Lecourt, Hélène; Dall'Olio, Filippo Gustavo; Aldea, Mihaela; Blanc-Durand, Felix; Vergé, Véronique; Quivoron, Cyril; Naltet, Charles; Abdayem, Pamela; Lavaud, Pernelle; Ghigna, Maria Rosa; Friboulet, Luc; Loriot, Yohann; De Botton, Stéphane; Ribrag, Vincent; Ardizzoni, Andrea; Planchard, David; Soria, Jean-Charles; Barlesi, Fabrice; Besse, Benjamin
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial
2024 Bria, Emilio; Morgillo, Floriana; Garassino, Marina Chiara; Ciardiello, Fortunato; Ardizzoni, Andrea; Stefani, Alessio; Verderame, Francesco; Morabito, Alessandro; Chella, Antonio; Tonini, Giuseppe; Gilli, Marina; Del Signore, Ester; Berardi, Rossana; Mencoboni, Manlio; Bearz, Alessandra; Delmonte, Angelo; Migliorino, Marta Rita; Gridelli, Cesare; Pazzola, Antonio; Iero, Manuela; De Marinis, Filippo
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial
2024 Garon, Edward B.; Lu, Shun; Goto, Yasushi; De Marchi, Pedro; Paz-Ares, Luis; Spigel, David R.; Thomas, Michael; Yang, James Chih-Hsin; Ardizzoni, Andrea; Barlesi, Fabrice; Orlov, Sergey; Yoshioka, Hiroshige; Mountzios, Giannis; Khanna, Sadhvi; Bossen, Claudia; Carbini, Mariana; Turri, Sabine; Myers, Andrea; Cho, Byoung Chul
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
2024 Felip, Enriqueta; Metro, Giulio; Soo, Ross A; Wolf, Jürgen; Solomon, Benjamin J; Tan, Daniel Sw; Ardizzoni, Andrea; Lee, Dae Ho; Sequist, Lecia V; Barlesi, Fabrice; Ponce-Aix, Santiago; Abreu, Delvys Rodriguez; Campelo, Maria Rosario Garcia; Sprauten, Mette; Djentuh, Leslie O'Sullivan; Smith, Nathalie; Jary, Aline; Belli, Riccardo; Glaser, Sabine; Zou, Mike; Cui, Xiaoming; Giovannini, Monica; Yang, James Chih-Hsin
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04-2016 | Gelsomino, Francesco; Boni, Luca; Tiseo, Marcello; Ricciardi, Serena; Rocco, Danilo; Cortinovis, ...Diego L; Proietto, Manuela; Cogoni, Alessio; Pasello, Giulia; Camerini, Andrea; Sperandi, Francesca; Colantonio, Ida; Metro, Giulio; Mazzoni, Francesca; Baldini, Editta; Veccia, Antonello; Bennicelli, Elisa; Cecilia Bettini, Anna; Tognetto, Michele; Ardizzoni, Andrea | 2025-01-01 | LUNG CANCER | - | 1.01 Articolo in rivista | Gelsomino_2025.pdf; mmc1.pdf |
| Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma | Francia, A.; Girone, C.; Filippini, D. M.; Querzoli, G.; Fermi, M.; Miroglio, C.; Montacci, E.; A...rdizzoni, A.; Lauriola, M.; Romaniello, D. | 2025-01-01 | - | - | 4.03 Poster | - |
| Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening | Francia, A.; Girone, C.; Filippini, D. M.; Querzoli, G.; Fermi, M.; Venturoli, S.; Degiovanni, A....; Castellano-Sanz, E.; Miroglio, C.; Montacci, E.; Ardizzoni, A.; Lauriola, M.; Romaniello, D. | 2025-01-01 | - | - | 4.03 Poster | - |
| Diagnostic Accuracy of Procalcitonin in the Diagnosis of Sepsis in Cancer Patients Hospitalized for Infection | Salvatore, V.; Viola, A.; Spezzano, A.; Aquilino, A.; Barili, L.; Caprino, M.; Floresta, M.; Momo...li, G.; Romiti, A.; Scurria, G.; Sirna, M.; Paccapelo, A.; Nannini, M.; Ardizzoni, A.; Giostra, F. | 2025-01-01 | CANCER REPORTS | - | 1.01 Articolo in rivista | Salvatore, et al. CNR2-8-e70384.pdf |
| First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study | Di Federico, A.; Wang, K.; Chen, M. F.; Barsouk, A. A.; Pagliaro, A.; Chen, L. N.; Ogliari, F. R....; Stockhammer, P.; Thawani, R.; Raslan, S.; Gariazzo, E.; Fusco, F.; Hambelton, G. M.; Citarella, F.; Meyer, D.; Aldea, M.; De Giglio, A.; Alessi, J. V.; Pecci, F.; Gelsomino, F.; Corassa, M.; Vokes, N. I.; Wang, X.; De Biase, D.; Abu Rous, F.; Areesawangkit, P.; Elghawy, O.; Cortellini, A.; Metro, G.; Ferrara, R.; Awad, M. M.; Pabani, A.; Murray, J. C.; Cappuzzo, F.; Garassino, M. C.; Dagogo-Jack, I.; Riely, G.; Grant, M.; Herzberg, B. O.; Ardizzoni, A.; Planchard, D.; Johnson, B. E.; Langer, C. J.; Offin, M.; Negrao, M. V.; Ricciuti, B. | 2025-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC | Pecci, F.; Li, H.; Di Federico, A.; Wu, J.; Chen, H.; Gariazzo, E.; Mantuano, F.; Garbo, E.; Alde...a, M.; Santo, V.; Gibbons, D.; Tran, H.; Paoloni, F.; De Almeida, G. R.; Metro, G.; De Giglio, A.; Gelsomino, F.; Wang, X.; Tiseo, M.; Rotow, J.; Ardizzoni, A.; Lee, J. J.; Awad, M. M.; Addeo, A.; Hong, L.; Negrao, M. V.; Janne, P. A.; Heymach, J. V.; Zhang, J.; Ricciuti, B.; Le, X. | 2025-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | ccr-25-1735.pdf |
| Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50% | De Giglio, A.; Zullo, L.; Di Federico, A.; Cani, M.; Aldea, M.; Soldato, D.; Dall'Olio, F. G.; Ma...ntuano, F.; Sperandi, F.; Favorito, V.; Sadowska, A.; Hendriks, L. E. L.; Gorria, T.; Mezquita, L.; Tabbo, F.; Novello, S.; Gelsomino, F.; Besse, B.; Ardizzoni, A. | 2025-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | degiglioetal_ESMOOPEN.pdf; mmc1 (1).pdf |
| Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis | Di Federico, A.; Stumpo, S.; Mantuano, F.; De Giglio, A.; Lo Bianco, F.; Pecci, F.; Alessi, J. V....; Wang, X.; Sperandi, F.; Melotti, B.; Gelsomino, F.; Skoulidis, F.; Garassino, M. C.; Peters, S.; Awad, M. M.; Ardizzoni, A.; Ricciuti, B. | 2025-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors | Di Federico, A; Hong, L; Elkrief, A; Thummalapalli, R; Cooper, A J; Ricciuti, B; Digumarthy, S; A...lessi, J V; Gogia, P; Pecci, F; Makarem, M; Gandhi, M M; Garbo, E; Saini, A; De Giglio, A; Favorito, V; Scalera, S; Cipriani, L; Marinelli, D; Haradon, D; Nguyen, T; Haradon, J; Voligny, E; Vaz, V; Gelsomino, F; Sperandi, F; Melotti, B; Ladanyi, M; Zhang, J; Gibbons, D L; Heymach, J V; Nishino, M; Lindsay, J; Rodig, S J; Pfaff, K; Sholl, L M; Wang, X; Johnson, B E; Jänne, P A; Rekhtman, N; Maugeri-Saccà, M; Heist, R S; Ardizzoni, A; Awad, M M; Arbour, K C; Schoenfeld, A J; Vokes, N I; Luo, J | 2025-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates | Dall'Olio, Filippo G; Zrafi, Wael; Roelants, Veronique; Ambrosini, Valentina; Fourquet, Aloyse; M...itea, Cristina; Passiglia, Francesco; Bauckneht, Matteo; Bonardel, Gerald; Conci, Nicole; Benitez, Jose Carlos; Arena, Vincenzo; Namour, Céline; Naigeon, Marie; Monnet, Isabelle; Beshiri, Kristi; Hoton, Delphine; Dursun, Safiye; Danlos, François Xavier; Argalia, Giulia; Aldea, Mihaela; Rovera, Guido; Derosa, Lisa; Iebba, Valerio; Gietema, Hester A; Gounant, Valerie; Lacroix, Valérie; Remon, Jordi; Gautheret, Daniel; Chaput, Nathalie; Job, Bastien; Kannouche, Patricia L; Velasco-Nuño, Monica; Zitvogel, Laurence; Cella, Eugenia; Chícharo De Freitas, José Reinaldo; Vasseur, Damien; Bettaieb, Mohamed Aymen; Tagliamento, Marco; Hendriks, Lizza; Italiano, Antoine; Planchard, David; Marabelle, Aurelien; Barlesi, Fabrice; Novello, Silvia; De Andreis, Desiree; Aboubakar Nana, Frank; Ardizzoni, Andrea; Zalcman, Gerard; Garcia, Camilo; Besse, Benjamin | 2025-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) | Angelicola, Stefania; Giunchi, Francesca; Ruzzi, Francesca; Frascino, Mariateresa; Pitzalis, Mary...; Scalambra, Laura; Semprini, Maria Sofia; Pittino, Olga Maria; Cappello, Chiara; Siracusa, Irene; Chillico, Ilaria Candida; Di Noia, Martina; Turato, Cristian; De Siervi, Silvia; Lescai, Francesco; Ciavattini, Teresa; Lopatriello, Giulia; Bertoli, Luca; De Jonge, Hugo; Iamele, Luisa; Altimari, Annalisa; Gruppioni, Elisa; Ardizzoni, Andrea; Rossato, Marzia; Gelsomino, Francesco; Lollini, Pier-Luigi; Palladini, Arianna | 2025-01-01 | JOURNAL OF TRANSLATIONAL MEDICINE | - | 1.01 Articolo in rivista | Hyperprog NSCLC JTranslMed.pdf; 12967_2024_6023_MOESM3_ESM.zip |
| Pembrolizumab-Induced Erosive Lichenoid Reaction in a Patient With Metastatic Lung Adenocarcinoma: A Case Report | Venturi, F.; Melotti, B.; Lambertini, M.; Alessandrini, A.; Ardizzoni, A.; Dika, E. | 2025-01-01 | INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY | - | 1.01 Articolo in rivista | pembrolizumab_induced_erosive_lichenoid_reaction.8.pdf |
| Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting | de Marinis, Filippo; Ardizzoni, Andrea; Attili, Ilaria; Bonanno, Laura; Bria, Emilio; Cortinovis,... Diego Luigi; Margaritora, Stefano; Mazzoni, Francesca; Mercadante, Edoardo; Morabito, Alessandro; Petrella, Francesco; Rea, Federico; Salvi, Rosario; Solli, Piergiorgio; Spaggiari, Lorenzo; Voltolini, Luca; Gridelli, Cesare | 2025-01-01 | CURRENT ONCOLOGY | - | 1.01 Articolo in rivista | De Marinis_Italian expert panel_perioperative_Current oncol_25.pdf; curroncol-32-00110-s001.zip |
| STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status | De Giglio, Andrea; De Biase, Dario; Favorito, Valentina; Maloberti, Thais; Di Federico, Alessandr...o; Zacchini, Federico; Venturi, Giulia; Parisi, Claudia; Gustavo Dall'Olio, Filippo; Ricciotti, Ilaria; Gagliano, Ambrogio; Melotti, Barbara; Sperandi, Francesca; Altimari, Annalisa; Gruppioni, Elisa; Tallini, Giovanni; Gelsomino, Francesco; Montanaro, Lorenzo; Ardizzoni, Andrea | 2025-01-01 | LUNG CANCER | - | 1.01 Articolo in rivista | STK11 mutations LUNG CANCER2025.pdf |
| Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer | Girone, Cinzia; Mazzeschi, Martina; Sgarzi, Michela; Pagano, Federica; Romaniello, Donatella; Mor...selli, Alessandra; Montacci, Elisa; Borrelli, Francesco; Miroglio, Chiara; Francia, Anna; Timmermans, Jasmine; Ambrosi, Francesca; Fiorentino, Michelangelo; Sargenti, Azzurra; Rihawi, Karim; Ardizzoni, Andrea; Lauriola, Mattia | 2024-01-01 | - | - | 4.03 Poster | - |
| Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO) | Pizzutilo, E G; Agostara, A G; Oresti, S; Signorelli, D; Stabile, S; Lauricella, C; Motta, V; Ama...tu, A; Ruggieri, L; Brambilla, M; Occhipinti, M; Proto, C; Giusti, R; Filetti, M; Genova, C; Barletta, G; Gelsomino, F; Bennati, C; Siringo, M; Di Fazio, G R; Russano, M; Montrone, M; Gariazzo, E; Roca, E; Bordi, P; Delmonte, A; Scimone, A; Belluomini, L; Mazzoni, F; Carta, A; Pelizzari, G; Viscardi, G; Morgillo, F; Gelibter, A; Gori, S; Berardi, R; Cortinovis, D; Ardizzoni, A; Veronese, S M; Sartore-Bianchi, A; Giannetta, L G; Cerea, G; Siena, S | 2024-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | 1-s2.0-S2059702924013619-main.pdf; 1-s2.0-S2059702924013619-mmc1.docx |
| Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience | Parisi, Claudia; Benitez, José Carlos; Lecourt, Hélène; Dall'Olio, Filippo Gustavo; Aldea, Mihael...a; Blanc-Durand, Felix; Vergé, Véronique; Quivoron, Cyril; Naltet, Charles; Abdayem, Pamela; Lavaud, Pernelle; Ghigna, Maria Rosa; Friboulet, Luc; Loriot, Yohann; De Botton, Stéphane; Ribrag, Vincent; Ardizzoni, Andrea; Planchard, David; Soria, Jean-Charles; Barlesi, Fabrice; Besse, Benjamin | 2024-01-01 | THE JOURNAL OF LIQUID BIOPSY | - | 1.01 Articolo in rivista | Parisi_ALK antibodies_J Liquid biopsy_24.pdf; mmc1 (2).docx |
| Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial | Bria, Emilio; Morgillo, Floriana; Garassino, Marina Chiara; Ciardiello, Fortunato; Ardizzoni, And...rea; Stefani, Alessio; Verderame, Francesco; Morabito, Alessandro; Chella, Antonio; Tonini, Giuseppe; Gilli, Marina; Del Signore, Ester; Berardi, Rossana; Mencoboni, Manlio; Bearz, Alessandra; Delmonte, Angelo; Migliorino, Marta Rita; Gridelli, Cesare; Pazzola, Antonio; Iero, Manuela; De Marinis, Filippo | 2024-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | Bria_Mauris_Oncologist_24.pdf; oyad342_suppl_supplementary_material.docx |
| Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial | Garon, Edward B.; Lu, Shun; Goto, Yasushi; De Marchi, Pedro; Paz-Ares, Luis; Spigel, David R.; Th...omas, Michael; Yang, James Chih-Hsin; Ardizzoni, Andrea; Barlesi, Fabrice; Orlov, Sergey; Yoshioka, Hiroshige; Mountzios, Giannis; Khanna, Sadhvi; Bossen, Claudia; Carbini, Mariana; Turri, Sabine; Myers, Andrea; Cho, Byoung Chul | 2024-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer | Felip, Enriqueta; Metro, Giulio; Soo, Ross A; Wolf, Jürgen; Solomon, Benjamin J; Tan, Daniel Sw; ...Ardizzoni, Andrea; Lee, Dae Ho; Sequist, Lecia V; Barlesi, Fabrice; Ponce-Aix, Santiago; Abreu, Delvys Rodriguez; Campelo, Maria Rosario Garcia; Sprauten, Mette; Djentuh, Leslie O'Sullivan; Smith, Nathalie; Jary, Aline; Belli, Riccardo; Glaser, Sabine; Zou, Mike; Cui, Xiaoming; Giovannini, Monica; Yang, James Chih-Hsin | 2024-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |